down arrow

North China Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000D16
CNY
5.84
-0.03 (-0.51%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
North China Pharmaceutical Co., Ltd.
Why is North China Pharmaceutical Co., Ltd. ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 3.23%
  • Poor long term growth as Net Sales has grown by an annual rate of -2.35% and Operating profit at 0.73% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2
With ROE of 5.12%, it has a expensive valuation with a 1.72 Price to Book Value
  • Over the past year, while the stock has generated a return of 0.69%, its profits have risen by 168.8% ; the PEG ratio of the company is 0.2
  • At the current price, the company has a high dividend yield of 0.5
3
Underperformed the market in the last 1 year
  • The stock has generated a return of 0.69% in the last 1 year, much lower than market (China Shanghai Composite) returns of 14.77%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is North China Pharmaceutical Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
North China Pharmaceutical Co., Ltd.
0.69%
0.94
31.72%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-2.35%
EBIT Growth (5y)
0.73%
EBIT to Interest (avg)
0.90
Debt to EBITDA (avg)
7.81
Net Debt to Equity (avg)
1.86
Sales to Capital Employed (avg)
0.60
Tax Ratio
31.01%
Dividend Payout Ratio
40.54%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.23%
ROE (avg)
1.59%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.72
EV to EBIT
28.82
EV to EBITDA
12.26
EV to Capital Employed
1.25
EV to Sales
2.01
PEG Ratio
0.20
Dividend Yield
0.55%
ROCE (Latest)
4.33%
ROE (Latest)
5.12%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
ROCE(HY)

Highest at 3.31%

INTEREST COVERAGE RATIO(Q)

Highest at 442.46

RAW MATERIAL COST(Y)

Fallen by 1.39% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.85%

NET SALES(Q)

Highest at CNY 2,668.68 MM

NET PROFIT(Q)

Highest at CNY 66.01 MM

EPS(Q)

Highest at CNY 0.04

-2What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 898.58 MM

Here's what is working for North China Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Highest at 442.46
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales
Highest at CNY 2,668.68 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Net Profit
Highest at CNY 66.01 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit
At CNY 66.01 MM has Grown at 58.73%
over average net sales of the previous four periods of CNY 41.58 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.04
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Inventory Turnover Ratio
Highest at 2.85%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by 1.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for North China Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at CNY 898.58 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."